MSD and Daiichi Sankyo pull HER3-DXd's FDA filing
MSD and Daiichi Sankyo suffer another setback with their HER3 programme ahead of a crucial data readout at ASCO.
Old COVID tweet lands Pfizer in new trouble with PMCPA
COVID-19 vaccine tweets from 2020 land Pfizer in trouble for promoting an unlicensed medicine - and reveal the pitfalls of linking content.
Moderna's $760m-plus flu vaccine contracts are nixed by HHS
HHS cancels funding for Moderna's pandemic flu vaccine development in a move viewed by some as an attack on mRNA technology.
Data sets up filing of new GSK antibiotic this year
GSK has said it will file its oral carbapenem antibiotic tebipenem HBr for approval before the end of this year as a treatment for complicated UTIs.
Eisai says patent win blocks Lenvima generic to 2036
Eisai has won a lawsuit blocking FDA approval of Shilpa's generic of cancer blockbuster Lenvima until 2036, although the verdict could go to appeal.
Sales & Marketing
Digital
Market Access
Oncology
Patients
R&D
Partner Content
Axtria Ignite 2025: Leading in an Agentic Era
Axtria’s flagship event is almost here! Axtria Ignite 2025 is taking place 4th to 5th June at the Princeton Marriott at Forrestal in New Jersey. This
Register Now for AAPS PharmSci 360!
Learn from pharmaceutical scientists involved at every stage of the drug development pipeline at PharmSci 360.
4th Annual Process Development for Cell Therapies Summit
Driving Process Robustness, Scalability, Speed & Affordability
Operationalize: Expanded Access Programs comes to the West C...
Improving Global Access to Life-Changing Therapeutics...
Injectable Drug Delivery 2025 – Driving Innovation Through C...
Press Release: Injectable Drug Delivery 2025 – Driving Innovation Through Collaboration LONDON, UK – 24–25 June 2025